SEI Investments
CCCC icon

SEI Investments’s C4 Therapeutics CCCC Stock Holding History

SEI Investments’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66.1K Buy
+25,134
New +$59.2K ﹤0.01% 3149
2025
Q2 		– Sell
-12,429
Closed -$19.9K – 2806
2025
Q1 		$19.9K Buy
12,429
+30
+0.2% +$89 ﹤0.01% 2741
2024
Q4 		$44.6K Buy
+12,399
New +$61.7K ﹤0.01% 2676
2023
Q3 		– Sell
-11,191
Closed -$30.8K – 2634
2023
Q2 		$30.8K Sell
11,191
-961
-8% -$3.09K ﹤0.01% 2635
2023
Q1 		$38.2K Buy
12,152
+917
+8% +$5.4K ﹤0.01% 2643
2022
Q4 		$66.3K Sell
11,235
-366
-3% -$3.04K ﹤0.01% 2470
2022
Q3 		$102K Buy
+11,601
New +$120K ﹤0.01% 2562

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SEI Investments's CCCC Position: Q1 2026 in Review

SEI Investments opened a new position in C4 Therapeutics (CCCC) in Q1 2026: 25,134 shares worth $66.1K. The stake represents ﹤0.01% of the portfolio and ranks #3149 among its holdings. This is a return to the name: SEI Investments previously reported a position in CCCC as recently as Q1 2025.

SEI Investments first reported a position in CCCC in Q3 2022 and has held it in 7 quarters since. The position peaked at $102K in Q3 2022. 123 funds tracked by Wall St. Rank hold CCCC as of Q1 2026.

  • SEI Investments held 25,134 shares of C4 Therapeutics worth $66.1K as of Q1 2026.
  • C4 Therapeutics was a new SEI Investments position in Q1 2026.
  • C4 Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #3149 holding.
  • SEI Investments first reported a position in C4 Therapeutics in Q3 2022 and has held it in 7 quarters since.
  • SEI Investments's C4 Therapeutics position peaked at $102K in Q3 2022.
  • 123 funds tracked by Wall St. Rank held C4 Therapeutics as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.